Part B Insider - 2022 Issue 11
Coding Update: Understand These Long-Term Drug Therapy Code Adjustments
Subscribe or sign in to view the full article.
Article Overview
This article explains a 2023 ICD-10-CM update to the long-term drug therapy category, with emphasis on how the revised Z79 family supports documentation for patients receiving ongoing medication therapy. It is aimed at coders and clinical documentation staff who need to recognize the updated structure, understand the general documentation implications, and follow the broader coverage and reporting considerations tied to these diagnoses.
Why This Topic Matters
Accurate reporting of long-term drug therapy can help complete the patient record, support medical decision making, and align documentation with coverage and monitoring requirements.
Article Sections
-
Refresh Your Z Code Knowledge
Introduces the long-term drug therapy Z code family and describes the scope of the ICD-10-CM update. It also places the revision in the context of supporting information used in patient encounters.
-
Document Everything That Affects MDM
Discusses the relationship between long-term drug therapy documentation and evaluation and management medical decision making. The section also covers general considerations about how treatment monitoring and coverage references may intersect with reporting.
What You Will Learn
- How the long-term drug therapy Z code family changed in the ICD-10-CM update
- Why documentation of ongoing medication therapy matters for patient records
- How this category can relate to evaluation and management medical decision making
- What broader coverage and monitoring considerations may be associated with these diagnoses
Who Should Read This
- Medical coders
- Coding educators
- Clinical documentation staff
- Primary care billing teams
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com